Boston, Massachusetts, USA
AI Proteins is on a mission to re-imagine protein-based medicines with ideal therapeutic characteristics. Since our founding in late 2021, our team of experienced protein engineers and drug developers has built a proprietary platform that leverages synthetic biology, robotics and automation, and artificial intelligence. This enables the company to rapidly design, build, and develop highly specific, durable, and inexpensive miniprotein medicines from scratch, with the potential for a variety of administration options.
Our de novo design capabilities give us complete structural control, allowing us to create patentable miniproteins that combine the most desirable characteristics of small molecules and biologics and possess nearly unlimited therapeutic potential. With an initial focus on inflammation, oncology, and metabolic diseases, we have identified novel candidates against a multitude of high value therapeutic targets, and we are currently advancing our own pipeline while also exploring partnerships to realize the full value of our innovations.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for AI Proteins on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
